📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

11ß-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial. (2020)

First Author: Markey K

Attributed to: Dissecting the steroid metabolome in the pathogenesis and treatment of metabolic liver disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/braincomms/fcz050

PubMed Identifier: 32954315

Publication URI: http://europepmc.org/abstract/MED/32954315

Type: Journal Article/Review

Volume: 2

Parent Publication: Brain communications

Issue: 1

ISSN: 2632-1297